Open original FDA record ↗Recall record
- FDA identifier
- Z-2691-2016
- Company in FDA record
- Elekta, Inc.
- FDA classification date
- Aug 30, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potentially unrecognized incorrect position of the treatment couch in 3D workflow, i.e. the HexaPOD has not moved fully to the 3D position.
Source facts
- Action
- Elekta sent an Important User Notice 618-03-303-025 to affected customers on 8/18/2016. The notice identified the affected product, problem, clinical impact, solution and actions to be taken. The Notice reminds users that the Interlock Check is not possible during 3D Workflow as iGUIDE is not in use. The notice reminds users that if iGUIDE is not being used - (A) Ensure the HexaPOD is at its pre-defined 3D position before treatment, and (B) Ensure the External Inhibit LED at the EnableSwitch Board is off. For questions contact your local Elekta office.
- Initiated
- 2016-08-18
- Root cause
- Nonconforming Material/Component
- Terminated
- 2017-05-23
- Distribution
- Worldwide Distribution - US Nationwide in the states of LA, PA, WA, and the countries of: Australia, Denmark, France, India, Italy, and Japan.
- Recall number
- Z-2691-2016
- Recall status
- Terminated
- CDRH record ID
- 148905
- FDA classified
- 2016-08-30
- Recall event number
- 74967